Genomenon Recognized by Frost & Sullivan for Genomic Intelligence Solutions and Software for Pharma and Clinical Diagnostics Companies
May 08, 2023
May 08, 2023
SAN ANTONIO, Texas, May 8 (TNSres) -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
Genomenon's unique blend of AI technology and expert scientific review delivers deep genomic insights into genetic drivers of rare diseases and cancer.
Frost & Sullivan today announced that it has awarded Genomenon with the 2023 Global Technology . . .
Genomenon's unique blend of AI technology and expert scientific review delivers deep genomic insights into genetic drivers of rare diseases and cancer.
Frost & Sullivan today announced that it has awarded Genomenon with the 2023 Global Technology . . .